These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8354475)

  • 1. [Role of individual genes in expression of phenotypic properties of the cold-adapted strain A/Leningrad/134/47/57 (H2N2)-a donor of attenuation of live influenza vaccine].
    Medvedeva TE; Kudriavtseva VK; Nevedomskaia GN; Zhikhareva IV; Gushchina MI; Zolotarev FN; Vodeĭko GM; Lisovskaia KV; Iotov VV; Khaĭder MI
    Genetika; 1993 Apr; 29(4):681-9. PubMed ID: 8354475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants.
    Palker T; Kiseleva I; Johnston K; Su Q; Toner T; Szymkowiak C; Kwan WS; Rubin B; Petrukhin L; Wlochowski J; Monteiro J; Kraiouchkine N; DiStefano D; Rudenko L; Shaw A; Youil R
    Virus Res; 2004 Oct; 105(2):183-94. PubMed ID: 15351492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
    Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL
    Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic properties resulting from directed gene segment reassortment between wild-type A/Sydney/5/97 influenza virus and the live attenuated vaccine strain.
    Parks CL; Latham T; Cahill A; O'neill RE; Passarotti CJ; Buonagurio DA; Bechert TM; D'Arco GA; Neumann G; Destefano J; Arendt HE; Obregon J; Shutyak L; Hamm S; Sidhu MS; Zamb TJ; Udem SA
    Virology; 2007 Oct; 367(2):275-87. PubMed ID: 17599381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mutations in the genes coding for hemagglutinin and neuraminidase in cold-adapted variants of the influenza virus A/Leningrad/134/57 (H2N2)].
    Medvedeva TE; Kudriavtseva VK; Zhikhareva IV; Romashkina VV; Aleksandrova GI; Klimov AI
    Vopr Virusol; 1991; 36(2):96-100. PubMed ID: 1882532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic and genetic analyses of the heterogeneous population present in the cold-adapted master donor strain: A/Leningrad/134/17/57 (H2N2).
    Youil R; Kiseleva I; Kwan WS; Szymkowiak C; Toner TJ; Su Q; Klimov A; Rudenko L; Shaw AR
    Virus Res; 2004 Jun; 102(2):165-76. PubMed ID: 15084398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2).
    Isakova-Sivak I; Chen LM; Matsuoka Y; Voeten JT; Kiseleva I; Heldens JG; den Bosch Hv; Klimov A; Rudenko L; Cox NJ; Donis RO
    Virology; 2011 Apr; 412(2):297-305. PubMed ID: 21315402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Location of ts defects in the genome of cold-adapted recombinant influenza A virus vaccine strains.
    Medvedeva TE; Lisovskaya KV; Polezhaev FI; Garmashova LM; Alexandrova GI; Ghendon YZ
    Acta Virol; 1984 May; 28(3):204-11. PubMed ID: 6147996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenic and isotype-specific responses to Russian and US cold-adapted influenza a vaccine donor strains A/Leningrad/134/17/57, A/Leningrad/134/47/57, and A/Ann Arbor/6/60 (H2N2) in mice.
    Wareing MD; Watson JM; Brooks MJ; Tannock GA
    J Med Virol; 2001 Sep; 65(1):171-7. PubMed ID: 11505460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary CD4+ cytokine responses in mice reveal differences in the relative immunogenicity of cold-adapted influenza A vaccine donor strains.
    Wareing MD; Harrison LC; Tannock GA
    Vaccine; 2005 Jul; 23(31):4075-81. PubMed ID: 15963362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reverse genetics studies of attenuation of the ca A/AA/6/60 influenza virus: the role of the matrix gene.
    Sweet TM; Maassab HF; Herlocher ML
    Biomed Pharmacother; 2004 Nov; 58(9):509-15. PubMed ID: 15511608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A/Ann Arbor/6/60 (H2N2).
    Cox NJ; Kitame F; Kendal AP; Maassab HF; Naeve C
    Virology; 1988 Dec; 167(2):554-67. PubMed ID: 2974219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuated ts-recombinants of influenza A/USSR/77 (H1N1) virus obtained by crossing with the cold-adapted donor A/Leningrad/134/57 (H2N2) virus.
    Polezhaev FI; Garmashova LM; Koval TA; Taranova GP; Topuriya NV; Aleksandrova GI
    Acta Virol; 1982 Jul; 26(4):221-6. PubMed ID: 6127928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
    Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
    Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genetic and phenotypic analysis of heterogeneous population of a cold-adapted donor of the A/Leningrad/134/17/57 (H2N2) attenuation and of the donor-based reassortant influenza vaccine strains].
    Kiseleva IV; Klimov AI; Grigor'eva EP; Larionova NV; Aleksandrova GI; Rudenko LG
    Vopr Virusol; 2005; 50(2):14-8. PubMed ID: 15881391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunogenicity of attenuated reassortants of influenza A virus /Leningrad/134/47/57 (H2N2) for mice, depending on their genome].
    Egorov AIu; Garmashova LM; Nevedomskaia GN; Bogomolova LI; Khaĭder AM; Aleksandrova GI
    Vopr Virusol; 1994; 39(5):198-201. PubMed ID: 7716900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Master donor viruses A/Leningrad/134/17/57 (H2N2) and B/USSR/60/69 and derived reassortants used in live attenuated influenza vaccine (LAIV) do not display neurovirulent properties in a mouse model.
    Voeten JT; Kiseleva IV; Glansbeek HL; Basten SM; Drieszen-van der Cruijsen SK; Rudenko LG; van den Bosch H; Heldens JG
    Arch Virol; 2010 Sep; 155(9):1391-9. PubMed ID: 20532926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Live cold-adapted influenza A vaccine produced in Vero cell line.
    Romanova J; Katinger D; Ferko B; Vcelar B; Sereinig S; Kuznetsov O; Stukova M; Erofeeva M; Kiselev O; Katinger H; Egorov A
    Virus Res; 2004 Jul; 103(1-2):187-93. PubMed ID: 15163508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic stability of live, cold-adapted influenza virus components of the FluMist/CAIV-T vaccine throughout the manufacturing process.
    Buonagurio DA; Bechert TM; Yang CF; Shutyak L; D'Arco GA; Kazachkov Y; Wang HP; Rojas EA; O'Neill RE; Spaete RR; Coelingh KL; Zamb TJ; Sidhu MS; Udem SA
    Vaccine; 2006 Mar; 24(12):2151-60. PubMed ID: 16413951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PB2 and PA genes control the expression of the temperature-sensitive phenotype of cold-adapted B/USSR/60/69 influenza master donor virus.
    Kiseleva IV; Voeten JT; Teley LC; Larionova NV; Drieszen-van der Cruijsen SK; Basten SM; Heldens JG; van den Bosch H; Rudenko LG
    J Gen Virol; 2010 Apr; 91(Pt 4):931-7. PubMed ID: 20007357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.